Two of the world’s leading dementia researchers are joining the UW faculty to identify what might be the earliest signs of cognitive decline. UW–Madison’s School of Medicine and Public Health is adding Henrik Zetterberg, a Swedish scientist who studies biomarkers, and Hartmuth Kolb, a German-born chemist and expert in imaging technology, to its faculty. Their goal is to identify chemicals in blood or spinal fluid — the biomarkers — that will show the likelihood of a person developing dementia.
Alzheimer’s disease is the most common form of dementia, affecting more than 55 million people — but it’s not the only kind. Dementia has no cure, though there are drugs that can slow the affliction’s progress.
Read the full article in the Summer 2025 edition of On Wisconsin magazine.
Pictured from left to right: Sterling Johnson, Phd, Henrik Zetterberg, MD, PhD, Cynthia Carlsson, MD, MS, Sanjay Asthana, MD, Hartmuth Kolb, PhD.
